| Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media. | |
| | |
MedLine Citation:
|
PMID: 9869558 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This multicenter, noncomparative, nonrandomized study evaluated the clinical efficacy and safety of ceftriaxone for treating acute otitis media in children following clinical failure of oral antibiotic therapy. Middle-ear fluid samples were collected on day 0 and on day 3, 4, or 5 (day 3 to 5) and were used to test whether ceftriaxone therapy can eradicate Streptococcus pneumoniae isolates with increased resistance to penicillin (MIC >/= 1 mg/liter). At the first visit, on day 0, middle-ear fluid was sampled for bacteriological testing by tympanocentesis or otorrhea pus suction. Patients were administered 50 mg of ceftriaxone/kg of body weight/day, injected intramuscularly once daily, for 3 days. A second sample was collected by tympanocentesis if a pneumococcus isolate for which the MIC of penicillin was >/=1 mg/liter was detected in the day-0 sample and if the middle-ear effusion persisted on day 3 to 5. This second sample was tested for bacterial eradication. One hundred eighty-six children aged 5 months to 5 years, 10 months, with acute otitis media clinical failure were enrolled and treated in this trial. On day 10 to 12, 145 (83.8%) of the 173 patients evaluable for clinical efficacy were clinically cured. Of the 59 patients infected by pneumococci, 36 had isolates for which the MICs of penicillin were >/=1 mg/liter. Of those patients, on day 10 to 12, 32 (88.9%) were clinically cured. Middle-ear fluid samples collected by day 3 to 5 following the onset of treatment with ceftriaxone were sterile for 24 of the 27 (88.9%) patients who were infected as of day 0 by pneumococci for which the MICs of penicillin were >/=1 mg/liter and who were evaluable for bacteriological eradication. On day 10 to 12, 81.4% of S. pneumoniae-infected children and 87.5% of Haemophilus influenzae-infected children were clinically cured. No discontinuation of treatment due to adverse events, particularly due to local reactions at the injection site, were reported. Only 11 adverse events which had doubtful, probable, or possible links with the study treatment were recorded. Both the bacteriologically assessed eradication of pneumococci for which the MICs of penicillin were >/=1 mg/liter and the clinical cure rates demonstrate that ceftriaxone is of value in the management of acute otitis media unresponsive to previous oral antibiotic therapy. |
| | |
Authors:
|
P Gehanno; L Nguyen; B Barry; M Derriennic; F Pichon; J M Goehrs; P Berche |
Related Documents
:
|
23052718 - Pain score of patients undergoing single spot, short pulse laser versus conventional la... 2063158 - Antibiotic prophylaxis in non-cardiac thoracic surgery. a double-blind study of penicil... 23416808 - The analgesic requirement after thyroid surgery under general anaesthesia with bilatera... 23328688 - Microvascular decompression for classic trigeminal neuralgia: determination of minimum ... 11743558 - Simultaneous aortic replacement and renal artery revascularization: the influence of pr... 17445638 - How small can we go? percutaneous nephrolithotomy using 6f nephroureteral catheter. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Antimicrobial agents and chemotherapy Volume: 43 ISSN: 0066-4804 ISO Abbreviation: Antimicrob. Agents Chemother. Publication Date: 1999 Jan |
Date Detail:
|
Created Date: 1999-03-25 Completed Date: 1999-03-25 Revised Date: 2013-04-17 |
Medline Journal Info:
|
Nlm Unique ID: 0315061 Medline TA: Antimicrob Agents Chemother Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 16-20 Citation Subset: IM |
Affiliation:
|
Service ORL, Hôpital Bichat, 75018 Paris, France. pierre.gehanno@bch.ap-hop-paris.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Ceftriaxone
/
adverse effects,
therapeutic use* Cephalosporins / adverse effects, therapeutic use* Child, Preschool Female Humans Infant Male Otitis Media / drug therapy*, microbiology Penicillin Resistance* Streptococcus pneumoniae / drug effects*, isolation & purification Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Cephalosporins; 73384-59-5/Ceftriaxone |
| Comments/Corrections | |
Erratum In:
|
Antimicrob Agents Chemother 1999 Jun;43(6):1532 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelia...
Next Document: Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CS...